Jaguar Health (JAGX) Cash & Current Investments (2016 - 2025)
Jaguar Health (JAGX) has disclosed Cash & Current Investments for 11 consecutive years, with $7.8 million as the latest value for Q4 2025.
- Quarterly Cash & Current Investments fell 2.12% to $7.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $7.8 million through Dec 2025, down 2.12% year-over-year, with the annual reading at $7.8 million for FY2025, 2.12% down from the prior year.
- Cash & Current Investments for Q4 2025 was $7.8 million at Jaguar Health, up from $3.5 million in the prior quarter.
- The five-year high for Cash & Current Investments was $32.2 million in Q1 2021, with the low at $2.2 million in Q2 2025.
- Average Cash & Current Investments over 5 years is $11.4 million, with a median of $9.8 million recorded in 2022.
- The sharpest move saw Cash & Current Investments soared 8211.86% in 2021, then plummeted 86.25% in 2025.
- Over 5 years, Cash & Current Investments stood at $17.1 million in 2021, then crashed by 67.93% to $5.5 million in 2022, then rose by 18.28% to $6.5 million in 2023, then grew by 23.7% to $8.0 million in 2024, then dropped by 2.12% to $7.8 million in 2025.
- According to Business Quant data, Cash & Current Investments over the past three periods came in at $7.8 million, $3.5 million, and $2.2 million for Q4 2025, Q3 2025, and Q2 2025 respectively.